Full Text View
Tabular View
No Study Results Posted
Related Studies
Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)
This study has been completed.
Study NCT00080262   Information provided by Bristol-Myers Squibb
First Received: March 25, 2004   Last Updated: June 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Metastases
Additional conditions recognized in this trial
Breast Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Ixabepilone
Additional drug interventions recognized in this trial
Epothilones
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services